Literature DB >> 9764586

Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions.

A Mutirangura1, V Sriuranpong, W Termrunggraunglert, D Tresukosol, P Lertsaguansinchai, N Voravud, S Niruthisard.   

Abstract

The purpose of this study was to define a correlation between telomerase activity and human papillomavirus (HPV) in normal control tissue and in benign, premalignant and malignant cervical lesions. Telomerase activity was detectable in 33 out of 34 cases of squamous-cell carcinoma, five out of six cases of microinvasive carcinoma, 8 out of 20 cases and two out of six cases of high- and low-grade squamous intraepithelial lesions (SILs) respectively. The higher frequency of positive telomerase in invasive carcinoma compared with SILs was observed in both HPV-associated and non-associated groups. Whereas 92.6% of HPV-positive and 100% of HPV-negative invasive lesions expressed telomerase, only 50% of HPV-positive and 25% of HPV-negative SILs did. Interestingly, telomerase activity was also detectable in 13 out of 28 cases of benign lesions regardless of the presence of HPV. In conclusion, there may be two roles of telomerase in the cervix. The first one would present in benign lesions; the second is associated with cancer development and activated during the late stage of multistep carcinogenesis in both HPV-positive and -negative groups.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764586      PMCID: PMC2063133          DOI: 10.1038/bjc.1998.604

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

Review 1.  Structure and function of telomeres.

Authors:  E H Blackburn
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

2.  The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop.

Authors: 
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

3.  Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers.

Authors:  R M Resnick; M T Cornelissen; D K Wright; G H Eichinger; H S Fox; J ter Schegget; M M Manos
Journal:  J Natl Cancer Inst       Date:  1990-09-19       Impact factor: 13.506

4.  Telomerase activation in in vitro and in vivo cervical carcinogenesis.

Authors:  P S Zheng; T Iwasaka; M Yokoyama; Y Nakao; A Pater; H Sugimori
Journal:  Gynecol Oncol       Date:  1997-08       Impact factor: 5.482

5.  The RNA component of human telomerase.

Authors:  J Feng; W D Funk; S S Wang; S L Weinrich; A A Avilion; C P Chiu; R R Adams; E Chang; R C Allsopp; J Yu
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

Review 6.  Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.

Authors:  J A DiPaolo; N C Popescu; L Alvarez; C D Woodworth
Journal:  Crit Rev Oncog       Date:  1993

7.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Authors:  M H Schiffman; H M Bauer; R N Hoover; A G Glass; D M Cadell; B B Rush; D R Scott; M E Sherman; R J Kurman; S Wacholder
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

8.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

9.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

10.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Authors:  C M Counter; A A Avilion; C E LeFeuvre; N G Stewart; C W Greider; C B Harley; S Bacchetti
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  12 in total

1.  Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.

Authors:  P L Cheah; L M Looi; M H Ng; V Sivanesaratnam
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

2.  Progressive transformation of immortalized esophageal epithelial cells.

Authors:  Zhong-Ying Shen; Li-Yan Xu; Min-Hua Chen; Jian Shen; Wei-Jia Cai; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  Telomerase activation and incidence of HPV in human gastrointestinal tumors in North Indian population.

Authors:  R C Sobti; J Kochar; K Singh; D Bhasin; N Capalash
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

4.  Potential of telomerase expression and activity in cervical specimens as a diagnostic tool.

Authors:  S Bravaccini; M A Sanchini; A Amadori; L Medri; L Saragoni; D Calistri; F Monti; A Volpi; D Amadori
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

5.  Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.

Authors:  Zhong-Ying Shen; Li-Yan Xu; En-Min Li; Wei-Jia Cai; Min-Hua Chen; Jian Shen; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity.

Authors:  Astrid C Baege; Allison Berger; Robert Schlegel; Tim Veldman; Richard Schlegel
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

7.  Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology.

Authors:  A N Y Cheung; P M Chiu; K L Tsun; U S Khoo; B S Y Leung; H Y S Ngan
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

8.  The status of telomerase enzyme activity in benign and malignant gynaecologic pathologies.

Authors:  Ilhami Gül; Ozgür Dündar; Serkan Bodur; Yusuf Tunca; Levent Tütüncü
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

Review 9.  Telomerase Induction in HPV Infection and Oncogenesis.

Authors:  Rachel Katzenellenbogen
Journal:  Viruses       Date:  2017-07-10       Impact factor: 5.048

10.  Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer.

Authors:  Nakarin Kitkumthorn; Pattamawadee Yanatatsanajit; Sorapop Kiatpongsan; Chureerat Phokaew; Surang Triratanachat; Prasert Trivijitsilp; Wichai Termrungruanglert; Damrong Tresukosol; Somchai Niruthisard; Apiwat Mutirangura
Journal:  BMC Cancer       Date:  2006-03-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.